Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic
The novel coronavirus has swept across the world in 2020 and ushered a new era. In the current scenario, it is not clear how patients with myeloproliferative neoplasms (including chronic myelogenous leukemia) should be managed, considering the risk of therapy, the need for social distancing and the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920300742 |
| _version_ | 1818516971116822528 |
|---|---|
| author | Fabio Pires de Souza Santos Renato Sampaio Tavares Katia Borgia Barbosa Pagnano |
| author_facet | Fabio Pires de Souza Santos Renato Sampaio Tavares Katia Borgia Barbosa Pagnano |
| author_sort | Fabio Pires de Souza Santos |
| collection | DOAJ |
| description | The novel coronavirus has swept across the world in 2020 and ushered a new era. In the current scenario, it is not clear how patients with myeloproliferative neoplasms (including chronic myelogenous leukemia) should be managed, considering the risk of therapy, the need for social distancing and the risk of untimely therapy discontinuation of delay. This guideline aims to give providers a sense of direction in order to better take care of patients and prioritize care. |
| first_indexed | 2024-12-11T00:49:37Z |
| format | Article |
| id | doaj.art-f9228ab76e6944e191ea363f9bc8b0ca |
| institution | Directory Open Access Journal |
| issn | 2531-1379 |
| language | English |
| last_indexed | 2024-12-11T00:49:37Z |
| publishDate | 2020-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj.art-f9228ab76e6944e191ea363f9bc8b0ca2022-12-22T01:26:40ZengElsevierHematology, Transfusion and Cell Therapy2531-13792020-07-01423195199Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemicFabio Pires de Souza Santos0Renato Sampaio Tavares1Katia Borgia Barbosa Pagnano2Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Hospital BP Mirante, São Paulo, SP, BrazilHospital das Clínicas da Universidade Federal de Goiás (HC UFG), Goiania, GO, Brazil; Corresponding author at: Faculdade de Medicina, Hospital das Clínicas da Universidade Federal de Goiás (UFG), Avenida 1, Setor Universitário, Goiania, GO, CEP: 74000-000, Brazil.Centro de Hematologia e Hemoterapia, Universidade Estadual de Campinas (Hemocentro Unicamp), Campinas, SP, BrazilThe novel coronavirus has swept across the world in 2020 and ushered a new era. In the current scenario, it is not clear how patients with myeloproliferative neoplasms (including chronic myelogenous leukemia) should be managed, considering the risk of therapy, the need for social distancing and the risk of untimely therapy discontinuation of delay. This guideline aims to give providers a sense of direction in order to better take care of patients and prioritize care.http://www.sciencedirect.com/science/article/pii/S2531137920300742Chronic myeloproliferative neoplasmsNovel coronavirusSARS-CoV2 pandemic |
| spellingShingle | Fabio Pires de Souza Santos Renato Sampaio Tavares Katia Borgia Barbosa Pagnano Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic Hematology, Transfusion and Cell Therapy Chronic myeloproliferative neoplasms Novel coronavirus SARS-CoV2 pandemic |
| title | Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic |
| title_full | Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic |
| title_fullStr | Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic |
| title_full_unstemmed | Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic |
| title_short | Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic |
| title_sort | guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus sars cov2 pandemic |
| topic | Chronic myeloproliferative neoplasms Novel coronavirus SARS-CoV2 pandemic |
| url | http://www.sciencedirect.com/science/article/pii/S2531137920300742 |
| work_keys_str_mv | AT fabiopiresdesouzasantos guidelinesfortherapyofpatientswithchronicmyeloproliferativeneoplasmsduringthenovelcoronavirussarscov2pandemic AT renatosampaiotavares guidelinesfortherapyofpatientswithchronicmyeloproliferativeneoplasmsduringthenovelcoronavirussarscov2pandemic AT katiaborgiabarbosapagnano guidelinesfortherapyofpatientswithchronicmyeloproliferativeneoplasmsduringthenovelcoronavirussarscov2pandemic |